Re: Impairment charge and proceeds of sale of BristeelAccording to the MD&A, the proceeds of the sale of Bristeel were used to pay down the amount of credit they were using from their borrowing facility, not wiping out the actual impairment itself which is only $370,000. Yet the impairment results in a very low net earnings for the three quarters of 2014, not the actual earniings from continued operations. This should reflect a much higher net earnings and a much higher share price as a result. Am I correct, or am I off base with this assessment? Comments ladies and gentlemen, please.